Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events

INTRODUCTION: Immunotherapies have improved the prognosis of many cancer patients including patients with advanced melanoma. Immune checkpoint receptors including CTLA-4 and PD-1 have been established as main therapeutic targets for immunotherapy of melanoma. Although monotherapy is effective in mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Benjamin, Bärenwaldt, Anne, Herzig, Petra, Zippelius, Alfred, Maul, Lara Valeska, Hess, Viviane, König, David, Läubli, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130408/
https://www.ncbi.nlm.nih.gov/pubmed/37122748
http://dx.doi.org/10.3389/fimmu.2023.1125111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130408/
https://www.ncbi.nlm.nih.gov/pubmed/37122748
http://dx.doi.org/10.3389/fimmu.2023.1125111

Ejemplares similares